Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder

Phase 3 Active not recruiting 500 enrolled Vanda Pharmaceuticals

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a single oral dose of VQW-765 compared to placebo in adults with social anxiety disorder.

Timeline

Start: 2025-09-22
Primary completion: 2026-12
Completion: 2027-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	VQW-765	Unknown	—	Oral

Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder

Summary

Timeline

Drugs

Indications